Icon
+91 94997 68112
Login Register

Risperdal Consta - (12.5, 25, 37.5, 50 mg/Vial;Injectable)

Risperidone Janssen Pharma
12.5, 25, 37.5, 50 mg/Vial;Injectable
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
 None
Less Than 5
 None
RISPERDAL CONSTA (risperidone) is indicated for the treatment of schizophrenia
Yes
**** ****** ** ***. **** ****** ***** * **** ** [***(*)*] ** ****** ******* (*** **, ****) *** *** *********. *****, ******* ******* **** **** ******, ***** *** ***** ** ********** *** *** *****. *** *** ******* ** **** ******* *** ******* ****** ******* (*** **, ****). **, ** ******** **** **** ****** **** ****** **** ******* ***** *** **, ****( *.* ***** ****** ** **** ******)
Risperdal Consta Patent 1 Patent 2 Patent 3 Patent 4
**** ****** ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
**** ****** *** \ ********* [***(*)*] ** ******* **** ***** *** ****
  1. *** *, **** : **** ****** ********* ***[***(*)*] ** *** ******** * ********* ** ************* **** ******* ** *** ’******* (*** **, ****) ****** (*** **-******)
  2. *** **, **** : ******* ****** ***** * **** ******* **** ****** ** ****** ******* (*** **, ****)
  3. *** *, **** : ******* ******* **** **** ******, ***** *** ***** ** ********** *** *** *****.
  4. *** *, **** : **** *** ***** ********

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.